Lipid-induced β-amyloid peptide assemblage fragmentation

Biophysical Journal

Volumn 91, Issue 11, 2006, Pages 4071-4080

  Widenbrant, Martin J O ^a   Rajadas, Jayakumar ^a   Sutardja, Christopher ^a   Fuller, Gerald G ^a  

^a Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; LIPID;

ARTICLE; ATOMIC FORCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FRAGMENTATION REACTION; LIPID MONOLAYER; PROTEIN INTERACTION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 33845356957     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.085944     Document Type: Article

References (54)

1. Sisodia, S. S., and P. H. S. George-Hyslop. 2002. Gamma-secretase, notch, Aβ and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3:281-290.
2. Greenfield, J. P., J. Tsai, G. K. Gouras, B. Hai, G. Thinakaran, F. Checler, S. S. Sisodia, P. Greengard, and H. X. Xu. 1999. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides. Proc. Natl. Acad. Sci. USA. 96:742-747.
3. Almeida, C., R. Takahashi, and G. Gouras. 2006. Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J. Neurosci. 26:4277-4288.
4. Fuentealba, R., G. Farias, J. Scheu, M. Bronfman, M. Marzolo, and N. Inestrosa. 2004. Signal transduction during amyloid-[β]-peptide neurotoxicity: role in Alzheimer disease. Brain Res. Rev. 476:275-289.
5. Verdier, Y., M. Zarándi, and B. Penke. 2004. Amyloid-β- peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci. 10:229-248.
6. Selkoe, D. J. 2003. Aging, amyloid, and Alzheimer's disease: a perspective in honor of Carl Cotman. Neurochem. Res. 28:1705-1713.
7. Lashuel, H. 2005. Membrane permeabilization: a common mechanism in protein-misfolding diseases. Sci. Aging Knowledge Env. 38:pe28.
8. Tanzi, R. E. 2005. The synaptic Aβ hypothesis of Alzheimer disease. Nat. Neurosci. 8:977-979.
9. Bitan, G., M. D. Kirkitadze, A. Lomakin, S. S. Vollers, G. B. Benedek, and D. B. Teplow. 2003. Amyloid beta protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA. 100:330-335.
10. Lacor, P. N., M. C. Buniel, L. Chang, S. J. Fernandez, Y. S. Gong, K. L. Viola, M. P. Lambert, P. T. Velasco, E. H. Bigio, C. E. Finch, G. A. Krafft, and W. L. Klein. 2004. Synaptic targeting by Alzheimer'srelated amyloid β-oligomers. J. Neurosci. 24:10191-10200.
11. Vetrivel, K. S., H. P. Cheng, W. Lin, T. Sakurai, T. Li, N. Nukina, P. C. Wong, H. A. Xu, and G. Thinakaran. 2004. Association of γ-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279:44945-44954.
12. Ravi, L. B., S. Poosala, D. Ahn, F. J. Chrest, E. L. Spangler, R. Jayakumar, E. Nagababu, J. G. Mohanty, M. Talan, D. K. Ingram, and J. M. Rifkind. 2005. Red cell interactions with amyloid-β (1-40) fibrils in a murine model. Neurobiol. Dis. 19:28-37.
13. Gelinas, D. S., K. DaSilva, D. Fenili, P. S. George-Hyslop, and J. McLaurin. 2004. Immunotherapy for Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 101:14657-14662.
14. Lombardo, J., E. Stern, M. McLellan, S. Kajdasz, G. Hickey, B. Bacskai, and B. Hyman. 2003. Amyloid-β antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J. Neurosci. 23:10879-10883.
15. Grimm, M. O. W., H. S. Grimm, A. J. Patzold, E. G. Zinser, R. Halonen, M. Duering, J. A. Tschape, B. D. Strooper, U. Muller, J. Shen, and T. Hartmann. 2005. Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin. Nat. Cell Biol. 7:1118-1123.
16. Devaux, P., and R. Morris. 2004. Transmembrane asymmetry and lateral domains in biological membranes. Traffic. 5:241-246.
17. Wawrezinieck, L., H. R. D. Marguet, and P.-F. Lenne. 2005. Fluorescence correlation spectroscopy diffusion laws to probe the submicron cell membrane organization. Biophys. J. 89:4029-4042.
18. Fujiwara, T., K. Ritchie, H. Murakoshi, K. Jacobson, and A. Kusumi. 2002. Phospholipids undergo hop diffusion in compartmentalized cell membrane. J. Cell Biol. 157:1071-1082.
19. Lommerse, P. H., H. P. Spaink, and T. Schmidt. 2004. In vivo plasma membrane organization: results of biophysical approaches. Biochim. Biophys. Acta Biomembr. 1664:119-131.
20. Sheetz, M., J. Sable, and H.-G. Döbereiner. 2006. Continuous membrane-cytoskeleton adhesion requires continuous accommodation to lipid and cytoskeleton dynamics. Annu. Rev. Biophys. Biomol. Struct. 35:417-434.
21. Forstner, M. B., D. S. Martin, A. M. Navar, and J. A. Kas. 2003. Simultaneous single-particle tracking and visualization of domain structure on lipid monolayers. Langmuir. 19:4876-4879.
22. Hu, Y. F., K. Y. C. Lee, and J. Israelachvili. 2003. Sealed minitrough for microscopy and long-term stability studies of Langmuir monolayers. Langmuir. 19:100-104.
23. Ekelund, K., E. Sparr, J. Engblom, H. Wennerstrom, and S. Engstrom. 1999. AFM study of lipid monolayers. 1. Pressure-induced phase behavior of single and mixed fatty acids. Langmuir. 15:6946-6949.
24. Stolz, M., D. Stoffler, U. Aebi, and C. Goldsbury. 2000. Monitoring biomolecular interactions by time-lapse atomic force microscopy. J. Struct. Biol. 131:171-180.
25. Arimon, M., I. Diez-Perez, M. J. Kogan, N. Durany, E. Giralt, F. Sanz, and X. Fernandez-Busquets. 2005. Fine structure study of a β(1-42) fibrillogenesis with atomic force microscopy. FASEB J. 19:1344-1346.
26. Kowalewski, T., and D. M. Holtzman. 1999. In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: new insights into mechanism of β-sheet formation. Proc. Natl. Acad. Sci. USA. 96:3688-3693.
27. Hong, Q. A., M. P. Sheetz, and E. L. Elson. 1991. Single-particle tracking - analysis of diffusion and flow in two-dimensional systems. Biophys. J. 60:910-921.
28. Saxton, M. J., and K. Jacobson. 1997. Single-particle tracking: applications to membrane dynamics. Annu. Rev. Biophys. Biomol. Struct. 26:373-399.
29. Yoshina-Ishii, C., and S. G. Boxer. 2003. Arrays of mobile tethered vesicles on supported lipid bilayers. J. Am. Chem. Soc. 125:3696-3697.
30. Moscho, A., O. Orwar, D. T. Chiu, B. P. Modi, and R. N. Zare. 1996. Rapid preparation of giant unilamellar vesicles. Proc. Natl. Acad. Sci. USA. 93:11443-11447.
31. Lakowicz, J. R. 1999. Principles of Fluorescence Spectroscopy, 2nd Ed. Kluwer Academic, New York.
32. Marine, S., E. Zamiara, S. Smith, E. Stec, J. McGarvey, O. Kornienko, G. Jiang, K. Wong, J. Stack, B. Zhang, M. Ferrer, and B. Strulovici. 2006. A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation. Anal. Biochem. In press.
33. Andra, J., H. Cock, P. Garidel, J. Howe, and K. Brandenburg. 2005. Investigation into the interaction of the phosphoporin PhoE with outer membrane lipids: physicochemical characterization and biological activity. Med. Chem. 1:537-546.
34. Birch, D., K. Suhling, A. Holmes, T. Salthammer, and R. Imhof. 1993. Metal ion quenching of perylene fluorescence in lipid bilayers. Pure Appl. Chem. 65:1687-1692.
35. Patel, R. C., U. Kumar, D. C. Lamb, J. S. Eid, M. Rocheville, M. Grant, A. Rani, T. Hazlett, S. C. Patel, E. Gratton, and Y. C. Patel. 2002. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc. Natl. Acad. Sci. USA. 99:3294-3299.
36. Lambert, M. P., A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, and W. L. Klein. 1998. Diffusible, nonfibrillar ligands derived from Aβ 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:6448-6453.
37. Michikawa, M., J. S. Gong, Q. W. Fan, N. Sawamura, and K. Yanagisawa. 2001. A novel action of Alzheimer's amyloid β-protein (Aβ): oligomeric Aβ promotes lipid release. J. Neurosci. 21:7226-7235.
38. Ambroggio, E. E., D. H. Kim, F. Separovic, C. J. Barrow, C. J. Barrow, K. J. Barnham, L. A. Bagatolli, and G. D. Fidelio. 2005. Surface behavior and lipid interaction of Alzheimer β-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys. J. 88:2706-2713.
39. Anguiano, M., R. J. Nowak, and P. T. Lansbury. 2002. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a porelike mechanism that may be relevant to type II diabetes. Biochemistry. 41:11338-11343.
40. Volles, M. J., and P. T. Lansbury. 2002. Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry. 41:4595-4602.
41. Zhang, Y., R. McLaughlin, C. Goodyer, and A. LeBlanc. 2002. Selective cytotoxicity of intracellular amyloid β-peptide (1-42) through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156:519-529.
42. Bagatolli, L. A., and E. Gratton. 1999. Two-photon fluorescence microscopy observation of shape changes at the phase transition in phospholipid giant unilamellar vesicles. Biophys. J. 77:2090-2101.
43. Nuscher, B., F. Kamp, T. Mehnert, S. Odoy, C. Haass, P. J. Kahle, and K. Beyer. 2004. Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study. J. Biol. Chem. 279:21966-21975.
44. Petkova, A. T., Y. Ishii, J. J. Balbach, O. N. Antzutkin, R. D. Leapman, F. Delaglio, and R. Tycko. 2002. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA. 99:16742-16747.
45. Johnson, S. J., T. M. Bayerl, D. C. McDermott, G. W. Adam, A. R. Rennie, R. K. Thomas, and E. Sackmann. 1991. Structure of an adsorbed dimyristoylphosphatidylcholine bilayer measured with specular reflection of neutrons. Biophys. J. 59:289-294.
46. Harper, J. D., S. S. Wong, C. M. Lieber, and P. T. Lansbury. 1999. Assembly of a β-amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry. 38:8972-8980.
47. Lin, H., R. Bhatia, and R. Lal. 2001. Amyloid β-protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15:2433-2444.
48. Weninger, S. C., and B. A. Yankner. 2001. Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat. Med. 7:527-528.
49. Raviv, U., D. J. Needleman, Y. L. Li, H. P. Miller, L. Wilson, and C. R. Safinya. 2005. Cationic liposome-microtubule complexes: pathways to the formation of two-state lipid-protein nanotubes with open or closed ends. Proc. Natl. Acad. Sci. USA. 102:11167-11172.
50. Tashima, Y., R. Oe, S. Lee, G. Sugihara, E. J. Chambers, M. Takahashi, and T. Yamada. 2004. The effect of cholesterol and monosialoganglioside (GM1) on the release and aggregation of amyloid β-peptide from liposomes prepared from brain membrane-like lipids. J. Biol. Chem. 279:17587-17595.
51. Heerklotz, H. 2002. Triton promotes domain formation in lipid raft mixtures. Biophys. J. 83:2693-2701.
52. Waschuk, S. A., E. A. Elton, A. A. Darabie, P. E. Fraser, and J. McLaurin. 2001. Cellular membrane composition defines Aβ-lipid interactions. J. Biol. Chem. 276:33561-33568.
53. Roher, A. E., M. O. Chaney, Y. M. Kuo, S. D. Webster, W. B. Stine, L. J. Haverkamp, A. S. Woods, R. J. Cotter, J. M. Tuohy, G. A. Krafft, B. S. Bonnell, and M. R. Emmerling. 1996. Morphology and toxicity of Aβ (1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271:20631-20635.
54. Jacobson, K., E. D. Sheets, and R. Simson. 1995. Revisiting the fluid mosaic model of membranes. Science. 268:1441-1442.